Gestione farmacologica dell’artrite reumatoide

Questa linea guida fornirà raccomandazioni sulla gestione dell’artrite reumatoide per la pratica canadese. Nuove raccomandazioni verranno aggiunte nel tempo e aggiornate, con la raccomandazione più recente, i riepiloghi delle prove e i riepiloghi delle prove delle decisioni disponibili attraverso il sito Web (www.rheum.ca).

Scarica e leggi il full text dell’articolo:

• Canadian Rheumatology Association living guidelines for the pharmacological management of rheumatoid arthritis with disease-modifying anti-rheumatic drugs
  Glen S Hazlewood, Jordi Pardo Pardo, Cheryl Barnabe, Orit Schieir, Claire E.H. Barber, Laurie Proulx, Dawn P. Richards, Peter Tugwell, Nick Bansback, Pooneh Akhavan, Claire Bombardier, Vivian Bykerk, Shahin Jamal, Majed Khraishi, Regina Taylor-Gjevre, Carter Thorne, Arnav Agarwal and Janet E Pope
  The Journal of Rheumatology July 2022, jrheum.220209; DOI: https://doi.org/10.3899/jrheum.220209

Articoli correlati:

1. Challenges in Managing and Preventing Rheumatoid Arthritis PainYvette C. Terrie et al., US Pharmacist, 2021
2. The current status and challenges in the diagnosis and treatment of rheumatoid arthritis in China: An annual report of 2019Xinping Tian et al., Rheumatology and Immunology Research, 2021
3. Canadian Rheumatology Association Recommendation for the Use of COVID-19 Vaccination for Patients With Autoimmune Rheumatic DiseasesGlen S. Hazlewood et al., J Rheumatol, 2021
4. 2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis – Arthritis Care & Research
5. Drug treatment algorithm and recommendations from the 2020 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis—secondary publication – Modern Rheumatology
6. Rheumatoid arthritis in adults: management – National Institute for Health and Care Excellence